Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 Oct 15;11(1):20523.
doi: 10.1038/s41598-021-99592-3.

Relationship between chronic kidney disease and sarcopenia

Affiliations
Observational Study

Relationship between chronic kidney disease and sarcopenia

Ming-Dian Yu et al. Sci Rep. .

Abstract

Few studies have investigated the relationship between sarcopenia and mild to moderate renal decline. This study aimed to investigate the relationship between chronic kidney disease (CKD) and sarcopenia. In total, 123 patients hospitalized with CKD and 57 healthy volunteers who underwent physical examination during the same period (control group) were analyzed. Body compositions were measured by dual-energy X-ray absorptiometry, and the relative appendicular skeletal muscle index (RASMI) was calculated. Muscular strength was evaluated using hydraulic hand dynamometer. Walking speed within 6 m was measured for muscular function assessment. Single-photon emission computed tomography was performed to measure the glomerular filtration rate of CKD patients, who were then divided into CKD1 (55 patients in CKD stages 1 and 2) and CKD2 (68 patients in CKD stages 3-5). RASMI showed a downward trend with CKD progression (P = 0.001). Multivariate logistic regression analysis showed that age and CKD progression were independent risk factors for sarcopenia. The morbidity of sarcopenia was significantly greater in CKD patients than in healthy volunteers, and the degree of muscle loss was closely related to CKD progression.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Flow diagram of selection between experimental group and control group.
Figure 2
Figure 2
Flow chart of sarcopenia screening and assessment.

References

    1. Zhang L, et al. Prevalence of chronic kidney disease in China: A cross-sectional survey. J. Lancet. 2012;379:815–822. doi: 10.1016/S0140-6736(12)60033-6. - DOI - PubMed
    1. Clark BC, Manini TM. Functional consequences of sarcopenia and dynapenia in the elderly. J. Curr. Opin. Clin. Nutr. Metab. Care. 2010;13:271–276. doi: 10.1097/MCO.0b013e328337819e. - DOI - PMC - PubMed
    1. Kim HY. Nutritional intervention for a patient with diabetic nephropathy. J. Clin. Nutr. Res. 2014;3:64–68. doi: 10.7762/cnr.2014.3.1.64. - DOI - PMC - PubMed
    1. Thompson DD. Aging and sarcopenia. J. Musculoskelet. Neuronal. Interact. 2007;7:344–345. - PubMed
    1. Kim JC, Kalantar-Zadeh K, Kopple JD. Frailty and protein-energy wasting in elderly patients with end stage kidney disease. J. Am. Soc. Nephrol. 2013;24:337–351. doi: 10.1681/ASN.2012010047. - DOI - PubMed

Publication types